Cogstate cleared by FDA to start marketing Cognigram in U.S.
Filed with ASX · · 2 pages · English
Watch Cogstate's latest callCogstate (ASX:CGS) Q4 2026 Earnings Call · Replay · Aug 17Read the transcript of Cogstate (ASX:CGS) Q4 2026 Earnings CallStory so far
Earlier from Cogstate
- FY17 Earnings Update
- Cogstate selected as preferred provider for Lilly
- Appendix 4D and Half-Year Financial Report
- Cogstate enters into agreement with Clinical Ink
- 2016 Financial Year Results
Later from Cogstate
- Interim Business Update
- Global Alzheimer Platform Foundation Selects Cogstate
- Appendix 4D & Half Year Financial Report
- S&P DJ Indices Announces March Quarterly Rebalance
- Cogstate Establishes Rare Disease and Pediatric Expertise
Follow Cogstate into a list and get an email when it puts out news.
Follow Cogstate